Healthy men help uncover drug interactions in Early-Stage trial
NCT ID NCT02783040
First seen Apr 17, 2026 · Last updated May 16, 2026 · Updated 5 times
Summary
This early-stage study looked at how a new drug called BI 425809 changes the way the body processes four common medicines (midazolam, warfarin, omeprazole, and digoxin). Thirteen healthy men took these medicines alone and then again while also taking BI 425809. The goal was to see if BI 425809 affects how much of the other drugs stay in the blood, which helps doctors understand safe dosing for future patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
1346.22.1 Boehringer Ingelheim Investigational Site
Biberach, Germany
Conditions
Explore the condition pages connected to this study.